Direct-To-Consumer (DTC) Laboratory Testing Market Report 2025

This Direct-To-Consumer (DTC) Laboratory Testing market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The direct-to-consumer (DTC) laboratory testing market size has grown exponentially in recent years. It will grow from $4.45 billion in 2024 to $5.79 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to growing prevalence of infectious and chronic diseases, increasing geriatric population, increasing use of miniaturized portable instruments, growing use of biomarker profiling, and growing demand for personalized medicine.

The direct-to-consumer (DTC) laboratory testing market size is expected to see exponential growth in the next few years. It will grow to $16.54 billion in 2029 at a compound annual growth rate (CAGR) of 30%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing emphasis on wellness and preventive healthcare, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and rise of telemedicine. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

The increasing occurrence of infectious diseases is expected to drive the growth of the direct-to-consumer (DTC) laboratory testing market in the future. Infectious diseases are illnesses caused by harmful microorganisms like bacteria, viruses, parasites, or fungi, which spread from person to person through direct or indirect contact, or via vectors such as insects or animals. The rate of infectious diseases is shaped by a combination of biological, environmental, social, and economic factors. DTC laboratory testing plays a key role in preventing, detecting, and managing these diseases by expanding access to testing, encouraging early intervention, and supporting public health initiatives through data collection and awareness. For example, in August 2024, the UK Health Security Agency (UKHSA) reported 368 measles cases in England in 2023, a nearly sevenfold increase from 53 cases in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. As a result, the growing prevalence of infectious diseases is fueling the expansion of the DTC laboratory testing market.

Key players in the DTC laboratory testing market are actively developing innovative solutions, such as mobile phlebotomy services, to improve convenience and accessibility for their customers. Mobile phlebotomy services entail bringing blood collection (phlebotomy) to the patient's location, typically their home or workplace, eliminating the need for patients to visit medical facilities for blood tests. For example, in July 2023, Quest Diagnostics Incorporated, a US-based company specializing in diagnostic testing and services, introduced Quest Mobile, a new service designed to simplify the specimen collection process for laboratory testing nationwide. Quest Mobile enables patients to conveniently schedule appointments for at-home specimen collection by skilled phlebotomists. This user-friendly option allows patients to undergo various laboratory tests from the comfort of their homes, ensuring ease and accessibility in the testing process.

In May 2023, Getlabs, a US-based provider of at-home diagnostic collections, collaborated with Nice Healthcare to enhance access to in-home healthcare services and lab testing. This strategic partnership aims to streamline the overall healthcare experience for individuals by leveraging the combined strengths of both entities. Nice Healthcare, a US-based provider of in-home and virtual primary care services, complements Getlabs' offerings, further expanding access to essential healthcare services and lab testing for individuals.

Major companies operating in the direct-to-consumer (DTC) laboratory testing market are Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, PerkinElmer Inc, Genesis Healthcare Co., Natera Inc, Sonora Quest Laboratories, Ancestry.com LLC, 23andMe Holding Co, Thorne HealthTech Inc, Metropolis Healthcare Limited, Color Health Inc, LetsGetChecked Inc., MyHeritage Ltd, Everlywell Inc, Complete Genomics Incorporated, DanteLabs Inc, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC., WellnessFX Inc, Ulta Lab Tests LLC, Any Lab Test Now Inc, Vitagene Inc.

North America was the largest region in the direct-to-consumer (DTC) laboratory testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the direct-to-consumer (DTC) laboratory testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the direct-to-consumer (DTC) laboratory testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Direct-to-consumer (DTC) laboratory testing involves a model wherein individuals directly order medical tests and receive their results, bypassing traditional healthcare providers or intermediaries. This model typically operates through online platforms or services, allowing consumers to choose from a range of available tests, place orders, provide specimens either at home or at designated collection sites, and subsequently receive results electronically.

The primary samples used in direct-to-consumer (DTC) laboratory testing include blood, urine, saliva, and others. Blood samples involve small amounts of blood collected for medical testing or analysis, encompassing various tests such as genetic testing, disease risk assessment testing, complete blood count (CBC), diabetes testing, thyroid-stimulating hormone (TSH) testing, among others. These tests find applications in diagnostics, research and development, and drug discovery and development, and are utilized by end-users including hospitals, clinics, specialty labs, and diagnostic centers.

The direct-to-consumer (DTC) laboratory testing research report is one of a series of new reports that provides direct-to-consumer (DTC) laboratory testing market statistics, including the direct-to-consumer (DTC) laboratory testing industry's global market size, regional shares, competitors with a direct-to-consumer (DTC) laboratory testing market share, detailed direct-to-consumer (DTC) laboratory testing market segments, market trends and opportunities, and any further data you may need to thrive in the direct-to-consumer (DTC) laboratory testing industry. This direct-to-consumer (DTC) laboratory testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The direct-to-consumer (DTC) laboratory testing market consists of revenues earned by entities by provide services such as accessibility, convenience, wellness screening, genetic testing, health monitoring, nutritional analysis, fitness and performance testing, ancestry testing, maternity testing, pharmacogenomics testing, and nutrigenomics testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-to-consumer (DTC) laboratory testing market also includes sales of home test kits, sample collection kits, point-of-care testing devices, sequencing kits, automated liquid handling systems, thermal cyclers, sterile swabs, wearable devices, and mobile apps or online platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.